These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17103070)

  • 1. Can surgical oncologists reliably predict the likelihood for non-SLN metastases in breast cancer patients?
    Smidt ML; Strobbe LJ; Groenewoud HM; der Wilt GJ; Van Zee KJ; Wobbes T
    Ann Surg Oncol; 2007 Feb; 14(2):615-20. PubMed ID: 17103070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
    van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
    Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram.
    Specht MC; Kattan MW; Gonen M; Fey J; Van Zee KJ
    Ann Surg Oncol; 2005 Aug; 12(8):654-9. PubMed ID: 16021535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands?
    Smidt ML; Kuster DM; van der Wilt GJ; Thunnissen FB; Van Zee KJ; Strobbe LJ
    Ann Surg Oncol; 2005 Dec; 12(12):1066-72. PubMed ID: 16244802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram.
    Cripe MH; Beran LC; Liang WC; Sickle-Santanello BJ
    Am J Surg; 2006 Oct; 192(4):484-7. PubMed ID: 16978955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system.
    Unal B; Gur AS; Kayiran O; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Clin Pract; 2008 Nov; 62(11):1785-91. PubMed ID: 19143863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
    Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
    Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2009 Jul; 16(7):1946-51. PubMed ID: 19408057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study.
    Gur AS; Unal B; Ozbek U; Ozmen V; Aydogan F; Gokgoz S; Gulluoglu BM; Aksaz E; Ozbas S; Baskan S; Koyuncu A; Soran A;
    Eur J Surg Oncol; 2010 Jan; 36(1):30-5. PubMed ID: 19535217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of Memorial Sloan-Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer.
    van den Hoven I; Kuijt GP; Voogd AC; van Beek MW; Roumen RM
    Br J Surg; 2010 Nov; 97(11):1653-8. PubMed ID: 20641050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy.
    Lambert LA; Ayers GD; Hwang RF; Hunt KK; Ross MI; Kuerer HM; Singletary SE; Babiera GV; Ames FC; Feig B; Lucci A; Krishnamurthy S; Meric-Bernstam F
    Ann Surg Oncol; 2006 Mar; 13(3):310-20. PubMed ID: 16463073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node.
    Perhavec A; Perme MP; Hocevar M; Besić N; Zgajnar J
    Breast Cancer Res Treat; 2010 Jan; 119(2):357-66. PubMed ID: 19787449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
    Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population.
    Klar M; Jochmann A; Foeldi M; Stumpf M; Gitsch G; Stickeler E; Watermann D
    Breast Cancer Res Treat; 2008 Dec; 112(3):523-31. PubMed ID: 18172758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High intersystem variability for the prediction of additional axillary non-sentinel lymph node involvement in individual patients with sentinel node-positive breast cancer.
    van den Hoven I; Kuijt GP; Voogd AC; Roumen RM
    Ann Surg Oncol; 2012 Jun; 19(6):1841-9. PubMed ID: 22207045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
    Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
    Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two models for the prediction of nonsentinel node metastases in breast cancer.
    Ponzone R; Maggiorotto F; Mariani L; Jacomuzzi ME; Magistris A; Mininanni P; Biglia N; Sismondi P
    Am J Surg; 2007 Jun; 193(6):686-92. PubMed ID: 17512277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
    D'Eredità G; Troilo VL; Giardina C; Napoli A; Rubini G; Fischetti F; Berardi T
    Clin Breast Cancer; 2010 Dec; 10(6):445-51. PubMed ID: 21147687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.